Weight-loss market to see 16 new drugs by 2029, report estimates
- 11-Sep-2024
The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently dominated by Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab, according to estimates from analysts at Morningstar and Pitchbook. In a joint report published on Monday, analysts estimated the […]
Weight-loss market lands at the pharmacy shelf
- 05-Aug-2024
As Eli Lilly’s weight-loss drug Zepbound gains ground in the US against Novo Nordisk’s Wegovy, some doctors say their guiding principle for writing prescriptions is simple: which drug can my patients actually get at the pharmacy? Lilly has quickly built a roughly 40% market share in the U.S. since it launched Zepbound in December, hitting […]
Wegovy: Genetic profile may predict best response to weight-loss drug
- 20-May-2024
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk’s weight-loss drug Wegovy, researchers reported on Monday. The study, released at the Digestive Disease Week meeting in Washington, found a 95% likelihood that patients with this genetic profile would be strong responders to the treatment. Given the expense […]
Wegovy, Ozempic NOT linked to increase in suicidal thoughts
- 05-Jan-2024
A large US study found no evidence that taking Novo Nordisk’s Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday. Both Ozempic for type 2 diabetes and the obesity treatment Wegovy have the same active ingredient, semaglutide. Instead, the analysis of electronic medical record data from more than 1.8 […]
Zepbound: Weight loss from drug reversed after stopping treatment
- 12-Dec-2023
Patients on Eli Lilly’s weight-loss drug Zepbound substantially regained weight nearly a year after stopping treatment, according to full results of a study published on Monday. The data, published in the journal JAMA, showed patients who were obese and without diabetes experienced a 14% weight regain nearly a year after they switched to a placebo […]
How well-off Brits still buy Ozempic online
- 18-Nov-2023
John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator. Kim Gradwell, a retired receptionist who developed type 2 diabetes nearly 20 years ago, isn’t sure where she’ll find her next dose. The medicine is Ozempic – designed for type 2 diabetes, a life-threatening condition. […]